{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:07:49Z","timestamp":1791198469406,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health","award":["RO1 AI071319-04"],"award-info":[{"award-number":["RO1 AI071319-04"]}]},{"name":"National Institute of Health","award":["U01 AI07787-01"],"award-info":[{"award-number":["U01 AI07787-01"]}]},{"name":"National Institute of Science and Technology for Vaccines\/Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)"},{"name":"Programa de Desenvolvimento de Tecnologia e Insumos em Sa\u00fade from Funda\u00e7\u00e3o Oswaldo Cruz (PDTIS-FIOCRUZ)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.vaccine.2011.04.044","type":"journal-article","created":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T13:28:39Z","timestamp":1304861319000},"page":"4476-4484","source":"Crossref","is-referenced-by-count":19,"title":["MyD88-dependent protective immunity elicited by adenovirus 5 expressing the surface antigen 1 from Toxoplasma gondii is mediated by CD8+ T lymphocytes"],"prefix":"10.1016","volume":"29","author":[{"given":"\u00c9rica A.","family":"Mendes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Br\u00e1ulia C.","family":"Caetano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus L.O.","family":"Penido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Bruna-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo T.","family":"Gazzinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.04.044_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.10.005","article-title":"Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications","volume":"132","author":"Hartman","year":"2008","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2011.04.044_bib0010","doi-asserted-by":"crossref","unstructured":"Draper SJ, Heeney JL. Viruses as vaccine vectors for infectious diseases and cancer. Nat Rev Microbiol;8(1):62\u201373.","DOI":"10.1038\/nrmicro2240"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.044_bib0015","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/hum.2008.011","article-title":"Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes","volume":"19","author":"Gao","year":"2008","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.044_bib0020","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1128\/JVI.01840-09","article-title":"Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection","volume":"84","author":"Bayer","year":"2010","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.04.044_bib0025","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.4049\/jimmunol.0900537","article-title":"Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination","volume":"184","author":"Holst","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.044_bib0030","doi-asserted-by":"crossref","first-page":"e1000798","DOI":"10.1371\/journal.ppat.1000798","article-title":"Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8T cells","volume":"6","author":"Makedonas","year":"2010","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.044_bib0035","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.4049\/jimmunol.1000338","article-title":"CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of tlr and nucleotide-binding oligomerization domain-like receptor signaling","volume":"185","author":"Lindsay","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.044_bib0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0749-3797(97)00064-0","article-title":"Prevention of adenoviral acute respiratory disease in Army recruits: cost-effectiveness of a military vaccination policy","volume":"14","author":"Howell","year":"1998","journal-title":"Am J Prev Med"},{"issue":"23","key":"10.1016\/j.vaccine.2011.04.044_bib0045","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.vaccine.2010.03.046","article-title":"Construction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strains","volume":"28","author":"Hidajat","year":"2010","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2011.04.044_bib0050","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1016\/j.vaccine.2009.09.055","article-title":"A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo","volume":"27","author":"Thacker","year":"2009","journal-title":"Vaccine"},{"issue":"6949","key":"10.1016\/j.vaccine.2011.04.044_bib0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.044_bib0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1086\/648591","article-title":"Comparative cell-mediated immunogenicity of DNA\/DNA. DNA\/adenovirus type 5 (Ad5), or Ad5\/Ad5 HIV-1 clade B gag vaccine prime-boost regimens","volume":"201","author":"Asmuth","year":"2010","journal-title":"J Infect Dis"},{"issue":"35","key":"10.1016\/j.vaccine.2011.04.044_bib0065","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1016\/j.vaccine.2008.05.091","article-title":"Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells","volume":"26","author":"Resende","year":"2008","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2011.04.044_bib0070","doi-asserted-by":"crossref","first-page":"11491","DOI":"10.1073\/pnas.191380898","article-title":"Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen","volume":"98","author":"Bruna-Romero","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"10.1016\/j.vaccine.2011.04.044_bib0075","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1016\/j.vaccine.2009.07.106","article-title":"Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys","volume":"27","author":"Rodriguez","year":"2009","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.044_bib0080","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1089\/hum.2006.17.898","article-title":"Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase","volume":"17","author":"Machado","year":"2006","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.044_bib0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/hum.2006.17.415","article-title":"Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of Toxoplasma gondii induces immune response and protection against infection in mice","volume":"17","author":"Caetano","year":"2006","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.044_bib0090","first-page":"261","article-title":"Protective immunization against murine cytomegalovirus infection using adenoviruses and poxviruses expressing hepatitis B virus chimeras","volume":"10","author":"de Andrade","year":"2007","journal-title":"Int Microbiol"},{"issue":"51","key":"10.1016\/j.vaccine.2011.04.044_bib0095","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1016\/j.vaccine.2009.09.030","article-title":"Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine","volume":"27","author":"Henderson","year":"2009","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2011.04.044_bib0100","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1073\/pnas.87.16.6191","article-title":"Role of early genes in pathogenesis of adenovirus pneumonia","volume":"87","author":"Ginsberg","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.044_bib0105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.immuni.2009.04.015","article-title":"Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo","volume":"31","author":"Di Paolo","year":"2009","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.vaccine.2011.04.044_bib0110","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.4049\/jimmunol.0804269","article-title":"Antiviral antibodies target adenovirus to phagolysosomes and amplify the innate immune response","volume":"182","author":"Zaiss","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.044_bib0115","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.181.3.2134","article-title":"Adenovirus vector-induced innate inflammatory mediators. MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo","volume":"181","author":"Appledorn","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.044_bib0120","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1128\/JVI.01936-06","article-title":"Adenovirus infection triggers a rapid. MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo","volume":"81","author":"Hartman","year":"2007","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2011.04.044_bib0125","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1128\/JVI.02192-06","article-title":"Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways","volume":"81","author":"Zhu","year":"2007","journal-title":"J Virol"},{"issue":"7183","key":"10.1016\/j.vaccine.2011.04.044_bib0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature06664","article-title":"The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response","volume":"452","author":"Muruve","year":"2008","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vaccine.2011.04.044_bib0135","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: a history of clinical observations","volume":"39","author":"Weiss","year":"2009","journal-title":"Int J Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.044_bib0140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pt.2010.01.009","article-title":"Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention","volume":"26","author":"Elmore","year":"2010","journal-title":"Trends Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.04.044_bib0145","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/CMR.11.2.267","article-title":"Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts","volume":"11","author":"Dubey","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2011.04.044_bib0150","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.4049\/jimmunol.147.10.3501","article-title":"A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice","volume":"147","author":"Khan","year":"1991","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.044_bib0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1086\/315186","article-title":"Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents","volume":"181","author":"Angus","year":"2000","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.044_bib0160","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1128\/IAI.69.3.1605-1612.2001","article-title":"Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii","volume":"69","author":"Bonenfant","year":"2001","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.044_bib0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/IAI.71.1.309-316.2003","article-title":"A GRA1 DNA vaccine primes cytolytic CD8+ T cells to control acute Toxoplasma gondii infection","volume":"71","author":"Scorza","year":"2003","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.044_bib0170","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CDLI.11.4.704-710.2004","article-title":"Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis","volume":"11","author":"Martin","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"36","key":"10.1016\/j.vaccine.2011.04.044_bib0175","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1016\/j.vaccine.2005.04.025","article-title":"Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice","volume":"23","author":"Mevelec","year":"2005","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.vaccine.2011.04.044_bib0180","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1016\/j.vaccine.2008.07.032","article-title":"Protective Th1 immune responses against chronic toxoplasmosis induced by a protein\u2013protein vaccine combination but not by its DNA\u2013protein counterpart","volume":"26","author":"Jongert","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.044_bib0185","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00436-009-1393-1","article-title":"Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice","volume":"105","author":"Liu","year":"2009","journal-title":"Parasitol Res"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.044_bib0190","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.4049\/jimmunol.143.9.3031","article-title":"Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A\u00d7B\/B\u00d7A recombinant inbred and B10 congenic mice","volume":"143","author":"McLeod","year":"1989","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.044_bib0195","first-page":"732","article-title":"A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice","volume":"74","author":"Suzuki","year":"1991","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.044_bib0200","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0020-7519(99)00152-6","article-title":"HLA-class II genes modify outcome of Toxoplasma gondii infection","volume":"29","author":"Mack","year":"1999","journal-title":"Int J Parasitol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.044_bib0205","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.4049\/jimmunol.152.9.4537","article-title":"Effects of human class I transgenes on Toxoplasma gondii cyst formation","volume":"152","author":"Brown","year":"1994","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2011.04.044_bib0210","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.4049\/jimmunol.145.10.3438","article-title":"Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection","volume":"145","author":"Brown","year":"1990","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.044_bib0215","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4049\/jimmunol.149.1.175","article-title":"Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii","volume":"149","author":"Gazzinelli","year":"1992","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.04.044_bib0220","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ni.1629","article-title":"Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum","volume":"9","author":"Blanchard","year":"2008","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2011.04.044_bib0225","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/593019","article-title":"Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes","volume":"198","author":"Frickel","year":"2008","journal-title":"J Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2011.04.044_bib0230","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.92.16.7257","article-title":"Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo","volume":"92","author":"Yang","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.vaccine.2011.04.044_bib0235","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4049\/jimmunol.153.6.2533","article-title":"Parasite-induced IL-12 stimulates early IFN-\u03b3 synthesis and resistance during acute infection with Toxoplasma gondii","volume":"153","author":"Gazzinelli","year":"1994","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2011.04.044_bib0240","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1128\/IAI.62.7.2818-2824.1994","article-title":"Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha","volume":"62","author":"Hunter","year":"1994","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.044_bib0245","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","article-title":"Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection","volume":"11","author":"Denkers","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2011.04.044_bib0250","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2307\/3281034","article-title":"Antigenic differences between endozoites and cystozoites of Toxoplasma gondii","volume":"69","author":"Lunde","year":"1983","journal-title":"J Parasitol"},{"key":"10.1016\/j.vaccine.2011.04.044_bib0255","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.1941.02820090001001","article-title":"Toxoplasmic encephalithes in children","volume":"116","author":"Sabin","year":"1941","journal-title":"J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.044_bib0260","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/JCM.38.4.1453-1460.2000","article-title":"Fractionation of membrane components from tachyzoite forms of Toxoplasma gondii: differential recognition by immunoglobulin M (IgM) and IgG present in sera from patients with acute or chronic toxoplasmosis","volume":"38","author":"Giraldo","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2011.04.044_bib0265","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1128\/IAI.67.11.5869-5876.1999","article-title":"Immune CD8+ T cells prevent reactivation of Toxoplasma gondii infection in the immunocompromised host","volume":"67","author":"Khan","year":"1999","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.044_bib0270","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2353\/ajpath.2010.090825","article-title":"Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells","volume":"176","author":"Suzuki","year":"2010","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.044_bib0275","doi-asserted-by":"crossref","first-page":"e1000815","DOI":"10.1371\/journal.ppat.1000815","article-title":"Differential regulation of effector- and central-memory responses to Toxoplasma gondii infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells","volume":"6","author":"Wilson","year":"2010","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.vaccine.2011.04.044_bib0280","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.vaccine.2011.04.044_bib0285","doi-asserted-by":"crossref","first-page":"e10842","DOI":"10.1371\/journal.pone.0010842","article-title":"Absence of both IL-7 and IL-15 severely impairs the development of CD8T cell response against Toxoplasma gondii","volume":"5","author":"Bhadra","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vaccine.2011.04.044_bib0290","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.vaccine.2004.05.012","article-title":"Life-long systemic protection in mice vaccinated with L. major and adenovirus IL-12 vector requires active infection, macrophages and intact lymph nodes","volume":"23","author":"Gabaglia","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.044_bib0295","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/JVI.76.1.127-135.2002","article-title":"Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response","volume":"76","author":"Molinier-Frenkel","year":"2002","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2011.04.044_bib0300","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/hum.2004.15.1157","article-title":"The innate immune response to adenovirus vectors","volume":"15","author":"Muruve","year":"2004","journal-title":"Hum Gene Ther"},{"issue":"11","key":"10.1016\/j.vaccine.2011.04.044_bib0305","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.4049\/jimmunol.140.11.3943","article-title":"Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+. L3T4+ T cells in mice","volume":"140","author":"Suzuki","year":"1988","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2011.04.044_bib0310","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-3024.2009.01146.x","article-title":"Major role for CD8T cells in the protection against Toxoplasma gondii following dendritic cell vaccination","volume":"31","author":"Guiton","year":"2009","journal-title":"Parasite Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.04.044_bib0315","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2249.1991.tb08150.x","article-title":"CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice","volume":"84","author":"Parker","year":"1991","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.04.044_bib0320","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.4049\/jimmunol.172.6.3704","article-title":"T cell-intrinsic expression of c-Rel regulates Th1 cell responses essential for resistance to Toxoplasma gondii","volume":"172","author":"Mason","year":"2004","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.04.044_bib0325","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.4049\/jimmunol.181.5.3464","article-title":"TLR adaptor MyD88 is essential for pathogen control during oral Toxoplasma gondii infection but not adaptive immunity induced by a vaccine strain of the parasite","volume":"181","author":"Sukhumavasi","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.044_bib0330","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4049\/jimmunol.0801980","article-title":"Innate immunity mediated by MyD88 signal is not essential for induction of lipopolysaccharide-specific B cell responses but is indispensable for protection against Salmonella enterica serovar Typhimurium infection","volume":"182","author":"Ko","year":"2009","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.044_bib0335","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.4049\/jimmunol.181.9.6447","article-title":"MyD88 signaling is not essential for induction of antigen-specific B cell responses but is indispensable for protection against Streptococcus pneumoniae infection following oral vaccination with attenuated Salmonella expressing PspA antigen","volume":"181","author":"Park","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.044_bib0340","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1189\/jlb.0408228","article-title":"Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy","volume":"88","author":"Krummen","year":"2010","journal-title":"J Leukoc Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T17:24:10Z","timestamp":1686072250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11005895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":68,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0264410X11005895"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}